The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/23037

Title:	The number of circulating monocytes as biomarkers of the clinical response to methotrexate in untreated patients with rheumatoid arthritis.
Authors:	Chara, Luis Sánchez-Atrio, Ana Pérez, Ana Cuende, Eduardo Albarrán, Fernando Turrión, Ana Chevarria, Julio del Barco, Angel Asunsolo Sánchez, Miguel A Monserrat, Jorge Prieto, Alfredo de la Hera, Antonio Sanz, Ignacio Diaz, David Alvarez-Mon, Melchor View more
Mesh:	Antigens, CD Arthritis, Rheumatoid Biomarkers CX3C Chemokine Receptor 1 Case-Control Studies Cell Count Demography Female Humans Male Methotrexate Middle Aged Monocytes ROC Curve Receptors, Chemokine Treatment Outcome Cell Movement View more
Issue Date:	16-Jan-2015
Citation:	J Transl Med.2015 Jan;(13):2
Abstract:	The aim of this work was to analyze the number and distribution of circulating monocytes, and of their CD14(+high)CD16(-), CD14(+high)CD16(+) and CD14(+low)CD16(+) subset cells, in treatment-naive patients with rheumatoid arthritis (RA), and to determine their value in predicting the clinical response to methotrexate (MTX) treatment.
PMID:	25592233
URI:	https://hdl.handle.net/20.500.12530/23037
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > FIB H. U. Príncipe de Asturias > Artículos

Files in This Item:

File	Description	Size	Format
PMC4310181.pdf		1.1 MB	Adobe PDF	View/Open